Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)

China flag China · Delayed Price · Currency is CNY
112.89
-1.71 (-1.49%)
Jun 18, 2026, 3:00 PM CST
Market Cap68.11B -45.3%
Revenue (ttm)8.60B -20.1%
Net Income1.90B -36.6%
EPS3.15 -36.6%
Shares Out 603.32M
PE Ratio35.81
Forward PE26.75
Dividend2.97 (2.63%)
Ex-Dividend Daten/a
Volume3,460,104
Open113.88
Previous Close114.60
Day's Range112.60 - 115.45
52-Week Range112.60 - 218.57
Beta0.35
AnalystsHold
Price Target181.65 (+60.91%)
Earnings DateAug 21, 2026

About SHA:600436

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals under the Pien Tze Huang brand name. It is also involved in the sale of food; production of skin, hair, and oral care daily products; biotechnology... [Read more]

Sector Healthcare
Founded 1956
Employees 2,886
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600436
Full Company Profile

Financial Performance

In 2025, SHA:600436's revenue was 9.00 billion, a decrease of -16.56% compared to the previous year's 10.79 billion. Earnings were 2.16 billion, a decrease of -27.49%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 600436 stock is "Hold." The 12-month stock price target is ¥181.65, which is an increase of 60.91% from the latest price.

Price Target
¥181.65
(60.91% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Zhangzhou Pientzehuang Pharmaceutical Annual report: H2 2025

Zhangzhou Pientzehuang Pharmaceutical has published its H2 2025 annual report on April 29, 2026.

7 weeks ago - Filings

Zhangzhou Pientzehuang Pharmaceutical Quarterly report: Q1 2026

Zhangzhou Pientzehuang Pharmaceutical has published its Q1 2026 quarterly earnings report on April 29, 2026.

7 weeks ago - Filings

Zhangzhou Pientzehuang Pharmaceutical Quarterly report: Q3 2025

Zhangzhou Pientzehuang Pharmaceutical has published its Q3 2025 quarterly earnings report on October 17, 2025.

8 months ago - Filings

Zhangzhou Pientzehuang Pharmaceutical Earnings release: H1 2025

Zhangzhou Pientzehuang Pharmaceutical released its H1 2025 earnings on August 22, 2025, summarizing the period's financial results.

10 months ago - Filings

Zhangzhou Pientzehuang Pharmaceutical Quarterly report: H1 2025

Zhangzhou Pientzehuang Pharmaceutical has published its H1 2025 quarterly earnings report on August 22, 2025.

10 months ago - Filings